Publication | Closed Access

Ketamine reduces amyloid β-protein degradation by suppressing neprilysin expression in primary cultured astrocytes

Molecular PhysiologyBiochemistryPrimary Cultured AstrocytesMedicineNeuropharmacologyDegenerative PathologyProtein MisfoldingNeuroprotectionNeuroscienceNeuropathologyPharmacologyProtein DegradationNeprilysin ExpressionAmyloid β-Protein Degradation